Abstract
The recent commercial availability of HLA B-27 antiserum now enables laboratories without prior experience in HLA typing to test for this antigen. False positive and false negative reactions frequently occur and require judicious interpretation. In our laboratory, 30 of 100 specimens were positive for B-27 and 70 were negative. Of the 30 positive, 10 (33%) failed to react against every antiserum tested. Twenty-nine of the 70 negative specimens (41%) reacted falsely with one or more B-27 antisera. A significant cause of false positive reactions was cross-reaction of the B-7 antigen with B-27 antisera (13 of 15 B-7 positive, B-27 negative specimens). For valid B-27 testing, use of more than one B-27 antiserum is included.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
